Linden Thomas Advisory Services LLC Boosts Position in The Cigna Group (NYSE:CI)

Linden Thomas Advisory Services LLC boosted its holdings in shares of The Cigna Group (NYSE:CI) by 29.9% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,201 shares of the health services provider’s stock after purchasing an additional 506 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in The Cigna Group were worth $608,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group during the 4th quarter worth approximately $34,000. Ulland Investment Advisors LLC grew its stake in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group during the 3rd quarter worth approximately $37,000. Harbor Capital Advisors Inc. acquired a new stake in shares of The Cigna Group during the 3rd quarter worth approximately $45,000. Finally, Intact Investment Management Inc. acquired a new stake in shares of The Cigna Group during the 3rd quarter worth approximately $69,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Stock Down 0.3 %

NYSE CI opened at $294.18 on Monday. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The business’s fifty day simple moving average is $297.18 and its 200-day simple moving average is $325.59. The firm has a market cap of $81.82 billion, a PE ratio of 27.75, a P/E/G ratio of 0.78 and a beta of 0.54.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same quarter in the previous year, the firm earned $6.77 EPS. The company’s quarterly revenue was up 29.8% compared to the same quarter last year. As a group, equities analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CI shares. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Truist Financial dropped their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Piper Sandler reissued an “overweight” rating and issued a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Barclays lifted their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Stephens reissued an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research note on Friday, November 1st. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group has an average rating of “Buy” and an average price target of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.